Oculis Holding AG

Oculis Holding AGverified

OCS

Price:

$19.7

Market Cap:

$828.38M

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Industry

Biotechnology

IPO Date

2021-05-18

Stock Exchange

NASDAQ

Ticker

OCS

The Enterprise Value as of December 2025 (TTM) for Oculis Holding AG (OCS) is 765.15M

According to Oculis Holding AG’s latest financial reports and current stock price. The company's current Enterprise Value is 765.15M. This represents a change of 21.82% compared to the average of 628.11M of the last 4 quarters.

Oculis Holding AG (OCS) Historical Enterprise Value (quarterly & annually)

How has OCS Enterprise Value performed in the past?

The mean historical Enterprise Value of Oculis Holding AG over the last ten years is 387.73M. The current 765.15M Enterprise Value has changed 19.63% with respect to the historical average. Over the past ten years (40 quarters), OCS's Enterprise Value was at its highest in in the March 2025 quarter at 753.19M. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

387.73M

Median

357.16M

Minimum

244.58M

Maximum

597.02M

Oculis Holding AG (OCS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oculis Holding AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 144.10%

Maximum Annual Enterprise Value = 597.02M

Minimum Annual Increase = -40.17%

Minimum Annual Enterprise Value = 244.58M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024597.02M144.10%
2023244.58M-40.17%
2022408.83M14.46%
2021357.16M7.89%

Oculis Holding AG (OCS) Average Enterprise Value

How has OCS Enterprise Value performed in the past?

The current Enterprise Value of Oculis Holding AG (OCS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

416.81M

5-year avg

387.73M

10-year avg

387.73M

Oculis Holding AG (OCS) Enterprise Value vs. Peers

How is OCS’s Enterprise Value compared to its peers?

Oculis Holding AG’s Enterprise Value is less than Xencor, Inc. (1.46B), less than Kodiak Sciences Inc. (1.30B), less than AnaptysBio, Inc. (1.10B), less than UroGen Pharma Ltd. (1.17B), less than Phathom Pharmaceuticals, Inc. (913.24M), less than Nurix Therapeutics, Inc. (1.36B), less than Nektar Therapeutics (1.22B), less than Sana Biotechnology, Inc. (1.39B), greater than BridgeBio Oncology Therapeutics Inc. (517.22M), less than Mind Medicine (MindMed) Inc. (919.17M),

Build a custom stock screener for Oculis Holding AG (OCS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oculis Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oculis Holding AG (OCS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oculis Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Oculis Holding AG's Enterprise Value?

What is the highest Enterprise Value for Oculis Holding AG (OCS)?

What is the 3-year average Enterprise Value for Oculis Holding AG (OCS)?

What is the 5-year average Enterprise Value for Oculis Holding AG (OCS)?

How does the current Enterprise Value for Oculis Holding AG (OCS) compare to its historical average?